Nucleic acid dye as well as preparation method and application thereof
By simplifying the preparation process, nucleic acid dyes are prepared by reacting acridine orange with alkyne-containing compounds, which solves the problems of long synthetic routes and difficult purification of GelGreen and achieves high-sensitivity nucleic acid detection.
Patent Information
- Application Number
- CN202411123357.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-15
AI Technical Summary
Existing nucleic acid dyes such as GelGreen have long synthetic routes, are difficult to purify, and are difficult to separate from monomers and dimers, resulting in complicated preparation methods.
Nucleic acid dyes were prepared using acridine orange and alkyne-containing compounds as raw materials through reflux reaction and silica gel column purification. The preparation process was simplified by combining the reaction of intermediate compounds and diazide compounds.
The prepared nucleic acid dyes showed good performance in gel imaging, exhibiting high sensitivity and being suitable for detecting low-concentration DNA.
Smart Images

Figure CN119019368A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of nucleic acid dyes, and in particular to a preparation method and application of nucleic acid dyes. Background Art
[0002] Nucleic acids, including DNA and RNA, are an important class of biological macromolecules, and the study of nucleic acids is crucial in the field of molecular biology. Since nucleic acids themselves are invisible and do not have optical properties such as fluorescence emission, the development of nucleic acid dyes has received widespread attention. Nucleic acid dyes mainly detect nucleic acids by interacting with nucleic acids, and the optical properties change before and after the interaction. For example, commonly used fluorescent dyes detect nucleic acids by changes in fluorescence intensity. Traditional nucleic acid dyes such as ethidium bromide (EB) have gradually been replaced by other dyes due to their strong genotoxicity and carcinogenicity.
[0003] The dyes currently used in gel electrophoresis mainly include SYBR series dyes, GoldView series dyes, GelGreen series dyes, etc. Among them, GelGreen uses acridine orange as a chromophore, has a dimer structure, has very low background fluorescence in an aqueous environment, is safe and low in toxicity, and is widely used. However, the synthesis route of GelGreen dye is long and difficult to purify. It is difficult to separate the monomer and dimer using common purification methods such as column chromatography. Therefore, it is necessary to provide a simpler preparation method for nucleic acid dyes. Summary of the invention
[0004] The present application provides a method for preparing a nucleic acid dye to solve the above problems.
[0005] The technical solution adopted by the present invention is as follows:
[0006] A nucleic acid dye, the structural formula of the nucleic acid dye is shown in Formula 1:
[0007]
[0008] Wherein, R1 and R2 are one of alkyl, alkoxy, alkylamino, alkylacyl, alkylsulfonyl, substituted aryl, heterocycle, aromatic heterocycle, and substituted aromatic heterocycle; Y - is an anion, wherein the anion is a halide ion or a sulfonate ion (OTs - ).
[0009] Furthermore, the preparation method of the nucleic acid dye comprises the following steps:
[0010] (1) Acridine orange and an alkynyl-containing compound in a molar ratio of 1:(2-10) are added to a solvent, and potassium carbonate is added to obtain a mixed solution 1. The mixed solution 1 is refluxed at 75-85° C. for 45-50 hours, and the reflux liquid is collected. The reflux liquid is filtered and eluted with dichloromethane and dried to obtain a crude product. The crude product is purified by a silica gel column to obtain an intermediate compound I. The intermediate compound I has a structural formula shown in Formula 2:
[0011]
[0012] (2) The intermediate compound I and the diazide compound are added to a tetrahydrofuran aqueous solution, and copper sulfate pentahydrate and sodium ascorbate are added to obtain a mixed solution 2. The mixed solution 2 is heated to 55-65° C. and allowed to react for 12-18 hours. The mixed solution 2 is then purified by a silica gel column and dried to obtain a nucleic acid dye.
[0013] Furthermore, in step (1), the structural formula of the alkynyl-containing compound is as shown in Formula 3:
[0014]
[0015] Furthermore, in step (2), the chemical structure of the diazide compound is:
[0016] N3-(CH2) n -N3 or N3-(CH2CH2O) n -N3, n=1~12.
[0017] Furthermore, in step (2), the mass ratio of the intermediate compound I to the diazide compound is 15-20:3-5.
[0018] Furthermore, the nucleic acid dye is used in gel imaging.
[0019] Furthermore, the nucleic acid dye is used in the preparation of nucleic acid gel imaging dye.
[0020] Furthermore, the nucleic acid dye is used in the preparation of gel imaging reagents.
[0021] Compared with the prior art, the embodiments of the present invention have the following beneficial effects:
[0022] The preparation method of the nucleic acid dye of the present application is simple, the prepared nucleic acid dye has a good application effect in gel imaging, and the nucleic acid dye prepared in the present application is applied in DNA detection with a low concentration and has the advantage of high sensitivity. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 Synthesis route of alkynyl-containing compound 2 in Example 1
[0024] Figure 2 Synthesis route of intermediate compound 3 in Example 1
[0025] Figure 3 Synthesis route of diazide compound 4 in Example 1
[0026] Figure 4 Synthesis route of nucleic acid dye I in Example 1
[0027] Figure 5 Example 1 Nucleic acid dye I prepared 1 H NMR spectrum
[0028] Figure 6 Synthesis route of diazide compound 5 in Example 2
[0029] Figure 7 Synthesis route of nucleic acid dye II in Example 2
[0030] Figure 8 Example 2 Nucleic acid dye I prepared 1 H NMR spectrum
[0031] Fig. 9 Nucleic acid dye I prepared in Example 1 of the present invention and its ultraviolet absorption spectrum of interaction with nucleic acid.
[0032] Fig.10 Nucleic acid dye I prepared in Example 1 of the present invention and its fluorescence emission spectrum of interaction with nucleic acid.
[0033] Fig.11 Nucleic acid dye II prepared in Example 2 of the present invention and its ultraviolet absorption spectrum of interaction with nucleic acid.
[0034] Fig.12 Nucleic acid dye II prepared in Example 2 of the present invention and its fluorescence emission spectrum of interaction with nucleic acid.
[0035] Fig.13 Image of an agarose gel with GelGreen dye.
[0036] Fig.14 Agarose gel image of nucleic acid dye I prepared in Example 1 of the present invention.
[0037] Fig.15 Agarose gel image of nucleic acid dye II prepared in Example 2 of the present invention. DETAILED DESCRIPTION
[0038] It should be understood that the present invention is not limited to the specific compositions, methods or schemes described herein. In addition, unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. It should also be understood that the terms used herein are only used for the purpose of describing specific embodiments and are not intended to limit the scope of the present invention, which is limited only by the claims. The experimental methods used in the examples are conventional methods unless otherwise specified; the materials, reagents, etc. used, unless otherwise specified, can be obtained from commercial sources.
[0039] Example 1
[0040] Preparation and characterization of dimer nucleic acid dye I.
[0041] (1) Preparation of alkynyl-containing compound 2
[0042] The specific steps are as follows: 694 mg of bromohexanoic acid and 181 mg of propargylamine are mixed in 50 ml of dichloromethane, 455 mL of triethylamine and 630 mg of EDC are added, and stirred at room temperature overnight. After adding 100 ml of water to quench, 100 ml of dichloromethane is added for extraction. After the organic phase is dried over anhydrous sodium sulfate, the filtrate is combined and the solvent is removed to obtain a crude product, which is purified by column chromatography using a silica gel column (the mass ratio of silica gel to crude product is 5:1), and the eluent is petroleum ether: ethyl acetate = 2:1. 570 mg of the intermediate product is collected and dried to obtain a light yellow solid. The intermediate product is dissolved in 50 ml of acetone, 442 mg of sodium iodide is added, and the reaction is carried out at 75°C for 12 hours. After cooling to room temperature, it is filtered and dried to obtain 480 mg of the product as a light yellow solid.
[0043] (2) Preparation of intermediate compound 3
[0044] The specific steps are as follows: 280 mg of acridine orange and 2 g of compound 2 are mixed in 10 ml of acetonitrile, and 800 mg of potassium carbonate is added thereto. The above mixture is heated to reflux for reaction for 48 h. After cooling to room temperature, it is filtered and washed with dichloromethane. The filtrate is combined and the solvent is removed to obtain a crude product, which is purified by column chromatography using a silica gel column (silica gel and crude product ratio of 5:1), and the eluent is dichloromethane: methanol = 20:1. 501 mg of the product is collected and dried to obtain a red solid.
[0045] (3) Preparation of diazide compound 4
[0046] The specific steps are as follows: 488 mg of 1,2-bis(2-chloroethoxy)ethane is dissolved in 5 ml of DMF, 373 mg of sodium azide and 860 mg of sodium iodide are added, and the mixture is reacted at 80° overnight. After cooling to room temperature, 50 ml of saturated brine and 50 ml of ethyl acetate are added for extraction. The organic phase is dried over anhydrous sodium sulfate and then spin-dried to obtain 610 mg of the product as a yellow oil.
[0047] (4) Preparation of Nucleic Acid Dye I
[0048] The specific steps are as follows: 90 mg of compound 3 and 16 mg of compound 4 are mixed in 10 ml of tetrahydrofuran and 5 ml of water, and 41 mg of copper sulfate pentahydrate and 65 mg of sodium ascorbate are added thereto. The mixture is heated to 60°C and reacted overnight. After cooling to room temperature, the solvent is evaporated and the product is purified by column chromatography using a silica gel column (silica gel and crude product ratio of 5:1), the eluent is dichloromethane: methanol = 15:1, and 83 mg of the product is collected and dried to obtain a red solid.
[0049] (5) The nucleic acid dye prepared in this example was subjected to NMR testing. 1 H NMR spectrum Figure 1 As shown; the specific NMR data of the dye are: 1 H NMR (400MHz, DMSO-d6) δ8.73 (s, 1H), 8.32 (t, J = 5.7Hz, 1H), 7.93–7.83 (m, 3H), 7.26 (dd,J=9.3,2.0Hz,2H),6.62–6.54(m,2H),4.64(t,J=8.1Hz,2H),4.47(t,J=5.2Hz, 2H),4.28(d,J=5.6Hz,2H),3.74(t,J=5.2Hz,2H),3.48(s,2H),3.26(s,12H),2.16( t, J=7.2Hz, 2H), 1.82 (t, J=7.8Hz, 2H), 1.66 (q, J=7.4Hz, 2H), 1.56 (d, J=8.8Hz, 2H).
[0050] Example 2
[0051] Preparation and Characterization of Dimeric Nucleic Acid Dye II
[0052] (1) Preparation of diazide compound 5
[0053] The specific steps are as follows: 460 mg of diethylene glycol dichloroethyl ester is dissolved in 5 ml of DMF, 360 mg of sodium azide and 800 mg of sodium iodide are added, and the mixture is reacted at 80° overnight. After cooling to room temperature, 50 ml of saturated brine and 50 ml of ethyl acetate are added for extraction. The organic phase is dried over anhydrous sodium sulfate and then spin-dried to obtain 470 mg of the product as a yellow oil.
[0054] (2) Preparation of Nucleic Acid Dye II
[0055] The specific steps are as follows: 180 mg of compound 3 and 40 mg of compound 5 are mixed in 30 ml of tetrahydrofuran and 15 ml of water, and 83 mg of copper sulfate pentahydrate and 130 mg of sodium ascorbate are added thereto. The mixture is heated to 60°C for reaction for 12 hours. After cooling to room temperature, the solvent is evaporated and the product is purified by column chromatography using a silica gel column (silica gel and crude product ratio of 5:1), the eluent is dichloromethane: methanol = 15:1, and 170 mg of the product is collected and dried to obtain a red solid.
[0056] (3) The nucleic acid dye prepared in this embodiment was subjected to NMR test. 1 H NMR spectrum Figure 2 As shown; the specific NMR data of the dye are: 1 H NMR (400MHz, DMSO-d6) δ8.73 (s, 1H), 8.32 (t, J = 5.8Hz, 1H), 7.95–7.82 (m, 3H), 7.2 6(d,J=9.3Hz,2H),6.58(s,2H),4.65(t,J=8.0Hz,2H),4.47(t,J=5.2Hz,2H),4.28 (d,J=5.6Hz,2H),3.77(t,J=5.2Hz,2H),3.48(t,J=4.6Hz,2H),3.26(s,12H),2.16 (t,J=7.2Hz,2H),1.82(d,J=8.7Hz,2H),1.66(q,J=7.6Hz,2H),1.60–1.50(m,2H).
[0057] Wherein, the preparation method of compound 3 is the same as that of Example 1.
[0058] Example 3
[0059] UV absorption detection of nucleic acid dyes I and II
[0060] The UV absorption spectra of nucleic acid dyes I and II in organic solvents, aqueous phases, and DNA binding in aqueous phases were detected using a UV-visible spectrophotometer. Nucleic acid dyes I and II were dissolved in DMSO, and the stock solution was 10 mM. 0.5 mL of nucleic acid dye I and II stock solution was added to 1 mL of methanol, 50 mM Tris-HCl (pH 7.4), and 0.1 mM dsDNA, and the UV absorption at 200 nm-600 nm was measured.
[0061] The results are as follows Figure 9-10As shown, in methanol solution, the final concentration of 5mM nucleic acid dyes I and II have the strongest ultraviolet absorption peaks at 502-504nm, and a shoulder peak at 472; in Tris-HCl solution, the maximum absorption peaks of nucleic acid dyes I and II are around 472nm, and there is a shoulder peak at 502-504nm; after adding dsDNA with a final concentration of 0.1mM to Tris-HCl, the peak shape of nucleic acid dyes I and II changes, the main peak at 472nm decreases, and the shoulder peak at 502-504nm increases, indicating that nucleic acid dyes I and II can bind to dsDNA and cause changes in their ultraviolet absorption spectra.
[0062] Example 4
[0063] Fluorescence detection of nucleic acid dyes I and II
[0064] The fluorescence emission spectra of nucleic acid dyes I and II and the fluorescence changes after adding DNA / RNA were detected using a fluorescence spectrometer. 10mM nucleic acid dye I and II stock solutions were diluted to 1mM with DMSO, 1mL nucleic acid dye I and II were added to 200mL methanol, 50mM Tris-HCl (pH7.4) and Tris-HCl containing 0.1mM dsDNA or 400ng RNA, respectively, and the fluorescence spectrometer parameters were set to Ex=472nm, V=500V, Ex Slit / Em Slit=5nm, and the fluorescence values were measured.
[0065] The results are as follows Figure 11-12 As shown in the figure, since nucleic acid dyes I and II are in a dispersed active state in the organic phase, they have maximum fluorescence emission at 528nm after excitation at 472nm; however, in the aqueous Tris solution, nucleic acid dyes are hydrophobically aggregated into an inactive form with almost no fluorescence; after RNA is added to the Tris solution, the fluorescence at 528nm increases significantly; after adding 0.1μM dsDNA, the fluorescence at 528nm increases sharply. The above results show that nucleic acid dyes I and II have almost no fluorescence in the background, but the fluorescence is significantly enhanced after binding with DNA / RNA, indicating that they are very good nucleic acid dyes.
[0066] Example 5
[0067] Applications of Nucleic Acid Stains: Agarose Gel Electrophoresis
[0068] Practical application of nucleic acid dyes I and II detected by agarose gel electrophoresis. 10mM nucleic acid dyes I and II were diluted 10000 times with 1*TAE and used to prepare 1% agarose gel. 1ng, 2ng, 5ng, 10ng, 20ng, 50ng, 100ng of DNA marker were spotted on 1% agarose gel. After electrophoresis at 130V for 30min, GelGreen was used as a reference control. The results are as follows: Figure 13-15As shown, the imaging shows that nucleic acid dyes I and II can detect as low as 20 ng DNA with clear bands.
[0069] In summary, compared with existing products, the nucleic acid dye prepared in the present application has a shorter synthesis step and simpler purification. By testing its optical properties such as ultraviolet absorption and fluorescence, as well as agarose gel electrophoresis, the dye has good performance.
[0070] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A nucleic acid dye, characterized in that The structural formula of the nucleic acid dye is shown in Formula 1: Wherein, R1 and R2 are one of alkyl, alkoxy, alkylamino, alkylacyl, alkylsulfonyl, substituted aryl, heterocycle, aromatic heterocycle, and substituted aromatic heterocycle; Y - is an anion, and the anion is a halide ion or a sulfonate ion.
2. The method for preparing a nucleic acid dye according to claim 1, wherein The following steps are involved: (1) Acridine orange and an alkynyl-containing compound in a mass ratio of 0.15 to 0.2:1 are added to a solvent, and potassium carbonate is added to obtain a mixed solution 1. The mixed solution 1 is refluxed at 75-85° C. for 45-50 hours, and the reflux liquid is collected. The reflux liquid is filtered and eluted with dichloromethane and dried to obtain a crude product. The crude product is purified by a silica gel column to obtain an intermediate compound I. The intermediate compound I has a structural formula shown in Formula 2: (2) The intermediate compound I and the diazide compound are added to a tetrahydrofuran aqueous solution, and copper sulfate pentahydrate and sodium ascorbate are added to obtain a mixed solution 2. The mixed solution 2 is heated to 55-65° C. and allowed to react for 12-18 hours. The mixed solution 2 is then purified by a silica gel column and dried to obtain a nucleic acid dye.
3. The method for preparing a nucleic acid dye according to claim 2, wherein: In step (1), the structural formula of the alkynyl-containing compound is shown in Formula 3:
4. The method for preparing a nucleic acid dye according to claim 2, wherein: In step (2), the chemical structural formula of the diazide compound is: N3-(CH2)n-N3 or N3-(CH2CH2O)n-N3, n=1~12.
5. The method for preparing a nucleic acid dye according to claim 2, wherein: In step (2), the mass ratio of the intermediate compound I to the diazide compound is 15-20:3-5.
6. Use of the nucleic acid dye according to claim 1 in gel imaging.
7. Use of the nucleic acid dye according to claim 1 in the preparation of nucleic acid gel imaging dye.
8. Use of the nucleic acid dye according to claim 1 in preparing a gel imaging reagent.
Citation Information
Patent Citations
Methods of using dyes in association with nucleic acid staining or detection and associated technology
CN101142326A
Detection of cells in a liquid sample
CN109642248A
Methods of using dyes in association with nucleic acid staining or detection
US8877437B1
